Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Rare Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Rare Neoplasm

Cancer Family

Rare Neoplasm

CI-CAN-00000048Explore in graph →

Non-malignant116 active trials3 approved drugs7 evidence items

NCIt: C7201

Overview
Statistics
Survival
Genomics3
Variants & evidence7
Drugs4
Trials361
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 129 Recruiting 98 Active Not Recruiting 35 Not Yet Recruiting 31 Unknown 27 Terminated 24 Withdrawn 7 Enrolling By Invitation 4 Suspended 3 No Longer Available 2 Available 1

PhaseAll Early Phase 1 7 N/A 41 Phase 1 72 Phase 2 144 Phase 3 20 Phase 4 4

No study matches these filters